In silico analyses of the tumor microenvironment highlight tumoral inflammation, a Th2 cytokine shift and a mesenchymal stem cell-like phenotype in advanced in basal cell carcinomas
Autor: | Ivan V. Litvinov, Scott Gunn, Philippe Lefrançois, Jennifer Gantchev, Denis Sasseville, Amelia Martínez Villarreal, Pingxing Xie |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Cell type Tumor microenvironment integumentary system Mesenchymal stem cell Inflammation Cell Biology Biology medicine.disease Biochemistry 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Immune system Stroma 030220 oncology & carcinogenesis medicine Cancer research Macrophage Basal cell carcinoma medicine.symptom Molecular Biology Research Article |
Zdroj: | J Cell Commun Signal |
ISSN: | 1873-961X 1873-9601 |
DOI: | 10.1007/s12079-020-00563-6 |
Popis: | Basal Cell Carcinoma (BCC) represents the most common form of all cancers. BCC is characteristically surrounded by a fibromyxoid stroma. Previous studies have suggested a shift towards a Th2 response, an increase in T regulatory lymphocytes and the presence of cancer-associated fibroblasts in the BCC tumor microenvironment. In this study, we aimed to further characterize the BCC tumor microenvironment in detail by analyzing BCC RNA-Sequencing data and correlating it with clinically-relevant features via in silico RNA deconvolution. Using immune cell type deconvolution by CIBERSORT, we have identified a brisk lymphocytic infiltration, and more abundant macrophages in BCC tumors compared to normal skin. Using cell type enrichment by xCell, we confirmed the observed immune infiltration in BCC tumors and compared them to normal skin. We observed a shift towards Th2 immunity in advanced and vismodegib-resistant tumors. Tumoral inflammation induced by macrophage activity was associated with advanced BCCs, while lymphocytic infiltration was most significant in non-advanced tumors, likely related to an adaptive anti-tumoral response. In advanced and vismodegib-resistant BCCs, mesenchymal stem cell-like properties were observed. Particularly in vismodegib-resistant BCCs, fibroblasts and adipocytes were found at high number, which ultimately may contribute to the decreased drug delivery to the tumor. In conclusion, this study has revealed notable BCC tumor microenvironment findings associated with important clinical features. Microenvironment-altering agents may be used locally for “routine” BCCs and systematically for advanced or resistant BCCs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12079-020-00563-6) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |